12.07.2022 • NewsPetrobasCepsaCEPSA Chemical

Petrobras Closes Deten Sale to CEPSA

Brazilian oil group Petrobras has finalized the sale of its entire 27.88% stake in linear alkyl benzene (LAB) producer Deten Quimica to Spanish energy and petrochemicals group CEPSA Quimica for 514 million Brazilian reais.

© CEPSA
© CEPSA

CEPSA already had an indirect stake in Deten of 69.94% and the transaction with Petrobras lifts its total stake in the Brazilian LAB specialist to 97.82%.

Deten is Brazil’s sole producer of LAB, used in the production of linear acid alkylbenzene sulfonate (LABSA), which it also produces. Based in the Camacari industrial center in the northeastern state of Bahia, Deten has capacity of 23,000 t/y LAB and 120,000 t/y LABSA.

Petrobras said the sale is part of an ongoing optimization of its portfolio. The company’s board of directors approved the deal with CEPSA in April, having started the sale process in June 2021.

Author: Elaine Burridge, Freelance Journalist

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.